Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$9.76 - $14.15 $30,880 - $44,770
-3,164 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$7.66 - $13.38 $24,236 - $42,334
3,164 New
3,164 $37,000
Q3 2020

Nov 12, 2020

SELL
$6.52 - $8.94 $82,647 - $113,323
-12,676 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$6.18 - $10.76 $408,034 - $710,429
-66,025 Reduced 83.89%
12,676 $95,000
Q1 2020

May 11, 2020

SELL
$6.03 - $15.24 $153,608 - $388,223
-25,474 Reduced 24.45%
78,701 $495,000
Q4 2019

Feb 14, 2020

BUY
$9.07 - $15.84 $944,867 - $1.65 Million
104,175 New
104,175 $1.58 Million

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.